Last Price
2.95
Today's Change
+0.20 (7.27%)
Day's Change
2.55 - 3.02
Trading Volume
237,097
Overview
Market Cap
103 Million
Shares Outstanding
35 Million
Avg Volume
434,085
Avg Price (50 Days)
2.66
Avg Price (200 Days)
7.09
PE Ratio
-4.92
EPS
-0.60
Earnings Announcement
27-Nov-2024
Previous Close
2.75
Open
2.77
Day's Range
2.552 - 3.0282
Year Range
1.078 - 46.0
Trading Volume
241,408
Price Change Highlight
1 Day Change
7.27%
5 Day Change
2.43%
1 Month Change
-4.53%
3 Month Change
-42.83%
6 Month Change
-68.72%
Ytd Change
-89.86%
1 Year Change
-89.86%
3 Year Change
-89.86%
5 Year Change
-89.86%
10 Year Change
-89.86%
Max Change
-89.86%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
2
CEO Morning Brief
US Goods Trade Deficit Surges to 2-1/2-year High on Jump in Imports
3
4
CEO Morning Brief
5
CEO Morning Brief
Meta Developing Its Own AI Search Engine, the Information Reports
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
